← Back to Compounds Recovery

TB-500

Thymosin Beta-4 Synthetic Analogue · Tβ4 Fragment

A synthetic analogue of the naturally occurring protein Thymosin Beta-4, studied for its role in promoting cell migration, angiogenesis and systemic tissue repair. Works synergistically with BPC-157 for comprehensive healing support.

Type
TB4 Analogue Peptide
Natural source
Present in all human cells
Primary effect
Cell migration · Angiogenesis
Reach
Systemic
FDA Status
Unapproved
Stack
Often with BPC-157

What Is TB-500?

TB-500 is a synthetic version of a fragment of Thymosin Beta-4 (Tβ4), a naturally occurring 43 amino acid protein present in virtually all human and animal cells. Thymosin Beta-4 plays a fundamental role in cell building and is one of the most abundant proteins in the body. TB-500 specifically contains the actin-binding domain of Tβ4 which is responsible for most of its biological activity.

Mechanism of Action

TB-500's primary mechanism involves its ability to upregulate actin — a cell-building protein essential to cell migration and proliferation. Key effects include: promotion of new blood vessel formation (angiogenesis) at injury sites; reduction of inflammation through downregulation of inflammatory markers; acceleration of cell migration to injury sites enabling faster repair; and promotion of stem cell differentiation into tissue-specific cells.

Unlike BPC-157 which tends to work most effectively at or near the injection site, TB-500 has demonstrated systemic reach — meaning it can promote healing at sites distant from the injection point, making it particularly useful for multiple simultaneous injuries or systemic inflammation.

Research Findings

Animal studies have demonstrated TB-500's effectiveness in healing cardiac muscle after heart attack (significant in post-cardiac patients), improving recovery from neurological injury, accelerating wound closure and tendon repair, and reducing inflammation in multiple tissue types. The compound has been used in veterinary medicine for racehorses for many years under the brand name Thymosin Beta-4.

TB-500 vs BPC-157

These two compounds are frequently stacked because they work through different but complementary mechanisms. BPC-157 primarily works locally and targets specific healing pathways; TB-500 works systemically and focuses on cell migration and angiogenesis. Together they provide broader and faster tissue repair than either compound alone — addressing both the local repair process and the systemic delivery of healing cells and blood supply to injury sites.

⚠ Research & Educational Purposes Only

All content is provided for research and educational purposes only. Nothing on this site constitutes medical advice. Always consult a qualified healthcare professional. Consulting and physician referral services coming soon.